The Impact of Isolated Increased Nuchal Translucency ≥95th Centile on Perinatal Outcome: A Prospective Cohort Study from a North Indian Genetic Center

 

 Permissions and Reprints

Abstract

Objectives The aim of this study was to determine the chromosomal abnormalities and other adverse outcomes like miscarriages, intrauterine deaths, structural defects, and genetic syndromes in fetuses with increased nuchal translucency (NT) more than or equal to 95th centile. This study also compared the outcomes in fetuses with NT between 95th and 99th centile and more than 99th centile.

Study Design A prospective cohort of 182 patients with isolated increased NT was evaluated by invasive testing. Fetal chromosomes were examined by fluorescent in situ hybridization and karyotype or chromosomal microarray. Euploid pregnancies were followed-up with level II ultrasound and fetal echocardiography. For pregnancies progressing to delivery, the neonates were followed-up till the age of 3 months. Final outcome was reported as normal or abnormal. Collated data for perinatal outcomes was analyzed and compared between fetuses with NT 95th and 99th centile (group I) and NT more than 99th centile (group II).

Results Of the 202 patients recruited, 182 patients consented for invasive testing and chromosomal analysis. Of the 182 patients, group I (NT 95–99th centile) included 92 patients and group II 90 patients. Chromosomal abnormalities were present in 50 (27.4%), 14 (7.6%) in group I, and 36 (19.4%) in group II. Of the 132 euploid pregnancies, adverse outcomes were present in 22 (16%) fetuses, 7 (5.3%) in group I, and 15(11.7%) in group II. A normal outcome was present in 110 (60.4%) pregnancies of the 182 fetuses with NT more than or equal to 95th centile. Normal outcome observed in group I was 77.1% and in group II, it was 43.4%.

Conclusion An increased NT is associated with poor perinatal outcomes in 39.6% patients. Chromosomal analysis and follow-up for adverse outcome in fetuses with NT more than or equal to 95th centile is important to enable a take home neonatal rate of 60.4%. No pregnancy with increased NT should be discontinued without detailed fetal evaluation for genetic disorders, structural malformation, and fetal growth.

Publication History

Article published online:
12 May 2023

© 2023. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

• References

• 1 International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR). Annual Report 2007 with data for 2005. Rome, Italy: The International Centre on Birth Defects; 2007
  Google Scholar
• 2 Roozbeh N, Azizi M, Darvish L. Pregnancy outcome of abnormal nuchal translucency: a systematic review. J Clin Diagn Res 2017; 11 (03) QC12-QC16
  PubMedGoogle Scholar
• 3 Bardi F, Bosschieter P, Verheij J. et al. Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?. Prenat Diagn 2020; 40 (02) 197-205
  CrossrefPubMedGoogle Scholar
• 4 Nicolaides KH. The 11–13 +6 Weeks Scan. London: Fetal Medicine Foundation; 2004. [cited2015May10]. Accessed March 3, 2023 at: http://www.fetalmedicine.com/synced/fmf/FMF-English.pdf
  Google Scholar
• 5 Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001; 17 (02) 102-105
  CrossrefPubMedGoogle Scholar
• 6 Sotiriadis A, Papatheodorou S, Makrydimas G. Neurodevelopmental outcome of fetuses with increased nuchal translucency and apparently normal prenatal and/or postnatal assessment: a systematic review. Ultrasound Obstet Gynecol 2012; 39 (01) 10-19
  CrossrefPubMedGoogle Scholar
• 7 Bilardo CM, Timmerman E, Pajkrt E, van Maarle M. Increased nuchal translucency in euploid fetuses–what should we be telling the parents?. Prenat Diagn 2010; 30 (02) 93-102
  CrossrefPubMedGoogle Scholar
• 8 Maya I, Yacobson S, Kahana S. et al. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis. Ultrasound Obstet Gynecol 2017; 50 (03) 332-335
  CrossrefPubMedGoogle Scholar
• 9 Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192 (04) 1005-1021 DOI: 10.1016/j.ajog.2004.12.093. Erratum in: Am J Obstet Gynecol. 2005 Jun;192(6):2096
  CrossrefPubMedGoogle Scholar
• 10 Shaffer LG, McGowan-Jordon J, Schmid M. , Eds. An International System for Human Cytogenetic Nomenclature. Karger Medical and Scientific Publisher; 2013
  Google Scholar
• 11 Crown Rump Length and Nuchal Translucency Calculator 1135 S Sunset, Suite 402, CA 91790,. West Covina: Focus Information Technology; 2019. . Accessed March 3, 2023 at: perinatology.com/calculators/Crown%20Rump%20and%20Nuchal%20Translucency.html
  Google Scholar
• 12 Accessed March 3, 2023 at: http://www.chem.agilent.com/library/applications/5988_9498_en_scanner_paper_72.pdf
• 13 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
  CrossrefPubMedGoogle Scholar
• 14 Landrum MJ, Lee JM, Benson M. et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 2016; 44 (D1): D862-D868
  CrossrefPubMedGoogle Scholar
• 15 Stenson PD, Matthew M, Edward V Ball. et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 2017; 136 (06) 665-677
  CrossrefPubMedGoogle Scholar
• 16 Mottaz A, David FP, Veuthey AL, Yip YL. Easy retrieval of single amino-acid polymorphisms and phenotype information using SwissVar. Bioinformatics 2010; 26 (06) 851-852
  CrossrefPubMedGoogle Scholar
• 17 1000 Genomes Project Consortium. et al., A global reference for human genetic variation. Nature 526 (7571): 68-74 2015;
  CrossrefPubMedGoogle Scholar
• 18 Exome Variant Server. NHLBI GO Exome Sequencing Project (ESP). Accessed May 1, 2023 at: http://evs.gs.washington.edu/EVS/
  Google Scholar
• 19 Nagasaki M, Yasuda J, Katsuoka F. et al; ToMMo Japanese Reference Panel Project. Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals. Nat Commun 2015; 6: 8018
  CrossrefPubMedGoogle Scholar
• 20 American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med 2013; 32 (06) 1083-1101
  CrossrefPubMedGoogle Scholar
• 21 Dane B, Dane C, Cetin A, Kiray M, Sivri D, Yayla M. Pregnancy outcome in fetuses with increased nuchal translucency. J Perinatol 2008; 28 (06) 400-404
  CrossrefPubMedGoogle Scholar
• 22 Lithner CU, Kublickas M, Sverker Ek. Pregnancy outcome for fetuses with increased nuchal translucency but normal karyotype. J Med Screen 2016; 23: 1-6
  CrossrefPubMedGoogle Scholar
• 23 Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191 (01) 45-67
  CrossrefPubMedGoogle Scholar
• 24 Bilardo CM, Müller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 2007; 30 (01) 11-18
  CrossrefPubMedGoogle Scholar
• 25 Tahmasebpour A, Rafiee NB, Ghaffari S, Jamal A. Increased nuchal translucency and pregnancy outcome. Iran J Public Health 2012; 41 (11) 92-97
  PubMedGoogle Scholar
• 26 Ayräs O, Tikkanen M, Eronen M, Paavonen J, Stefanovic V. Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenat Diagn 2013; 33 (09) 856-862 Erratum in: Prenat Diagn. 2016 Feb;36(2):199
  CrossrefPubMedGoogle Scholar
• 27 Grande M, Jansen FA, Blumenfeld YJ. et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 46 (06) 650-658
  CrossrefPubMedGoogle Scholar
• 28 Saldanha FA, Brizot Mde L, Moraes EA, Lopes LM, Zugaib M. Increased fetal nuchal translucency thickness and normal karyotype: prenatal and postnatal follow-up [in Portuguese]. Rev Assoc Med Bras (1992) 2009; 55 (05) 575-580
  Google Scholar
• 29 Bakker M, Pajkrt E, Bilardo CM. Increased nuchal translucency with normal karyotype and anomaly scan: what next?. Best Pract Res Clin Obstet Gynaecol 2014; 28 (03) 355-366
  CrossrefPubMedGoogle Scholar
• 30 Pergament E, Alamillo C, Sak K, Fiddler M. Genetic assessment following increased nuchal translucency and normal karyotype. Prenat Diagn 2011; 31 (03) 307-310
  CrossrefPubMedGoogle Scholar
• 31 Coletta Lucas J. Increased nuchal translucency and normal karyotype: Value of additional testing. Am J Obstet Gynecol 2014; 208: 85-87
  Google Scholar
• 32 Mula R, Goncé A, Bennásar M. et al. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age. Ultrasound Obstet Gynecol 2012; 39 (01) 34-41
  CrossrefPubMedGoogle Scholar
• 33 Carss KJ, Hillman SC, Parthiban V. et al. Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet 2014; 23 (12) 3269-3277
  CrossrefPubMedGoogle Scholar
• 34 Hillman SC, Willams D, Carss KJ, McMullan DJ, Hurles ME, Kilby MD. Prenatal exome sequencing for fetuses with structural abnormalities: the next step. Ultrasound Obstet Gynecol 2015; 45 (01) 4-9
  CrossrefPubMedGoogle Scholar
• 35 Xue S, Yan H, Chen J. et al. Genetic examination for fetuses with increased fetal nuchal translucency by genomic technology. Cytogenet Genome Res 2020; 160 (02) 57-62
  CrossrefPubMedGoogle Scholar
• 36 Choy KW, Wang H, Shi M. et al. Prenatal diagnosis of fetuses with increased nuchal translucency by genome sequencing analysis. Front Genet 2019; 10: 761
  CrossrefPubMedGoogle Scholar
• 37 Petrovski S, Aggarwal V, Giordano JL. et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet 2019; 393 (10173): 758-767
  CrossrefPubMedGoogle Scholar
• 38 Khalil A, Mahmoodian N, Kulkarni A. et al. Estimation of detection rates of aneuploidy in high-risk pregnancy using an approach based on nuchal translucency and non-invasive prenatal testing: a cohort study. Fetal Diagn Ther 2015; 38 (04) 254-261
  CrossrefPubMedGoogle Scholar
• 39 Huang L-Y, Pan M, Han J, Zhen L, Yang X, Li DZ. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?. J Obstet Gynaecol 2018; 38 (04) 498-501
  CrossrefPubMedGoogle Scholar
• 40 Beulen L, Faas BHW, Feenstra I, van Vugt JMG, Bekker MN. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies. Ultrasound Obstet Gynecol 2017; 49 (06) 721-728
  CrossrefPubMedGoogle Scholar
• 41 Petersen OB, Smith E, Van Opstal D. et al. Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review. Acta Obstet Gynecol Scand 2020; 99 (06) 765-774
  CrossrefPubMedGoogle Scholar
• 42 Mellis R, Eberhardt RY, Hamilton SJ. et al; PAGE Consortium. Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it?. BJOG 2022; 129 (01) 52-61
  CrossrefPubMedGoogle Scholar